| Cohort | M0 | M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | M11 | M12 | M13 | M14 | M15 | M16 | M17 | M18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2025 | 100% | 110% | 112% | 110% | 110% | 100% | 100% | 100% | 120% | 118% | 112% | 112% | 112% | 95% | 112% | 112% | 112% | 112% | 112% |
| Apr 2025 | 100% | 100% | 100% | 100% | 99% | 99% | 103% | 103% | 103% | 114% | 109% | 109% | 116% | 116% | 116% | 116% | 116% | 116% | |
| May 2025 | 100% | 100% | 100% | 107% | 107% | 107% | 107% | 104% | 100% | 100% | 105% | 112% | 107% | 107% | 107% | 107% | 111% | ||
| Jun 2025 | 100% | 100% | 100% | 101% | 101% | 101% | 101% | 100% | 98% | 97% | 97% | 97% | 116% | 113% | 113% | 113% | |||
| Jul 2025 | 100% | 100% | 99% | 97% | 97% | 97% | 97% | 94% | 92% | 100% | 100% | 100% | 106% | 106% | 106% | ||||
| Aug 2025 | 100% | 100% | 99% | 99% | 106% | 106% | 106% | 106% | 106% | 106% | 106% | 106% | 107% | 107% | |||||
| Sep 2025 | 100% | 96% | 105% | 105% | 106% | 115% | 114% | 114% | 114% | 114% | 114% | 114% | 106% | ||||||
| Oct 2025 | 100% | 110% | 119% | 124% | 124% | 124% | 124% | 124% | 126% | 138% | 138% | 138% | |||||||
| Nov 2025 | 100% | 100% | 104% | 107% | 107% | 107% | 111% | 111% | 111% | 111% | 111% | ||||||||
| Dec 2025 | 100% | 98% | 98% | 95% | 95% | 95% | 114% | 114% | 111% | 111% | |||||||||
| Jan 2026 | 100% | 100% | 94% | 94% | 94% | 94% | 94% | 100% | 110% | ||||||||||
| Feb 2026 | 100% | 98% | 98% | 98% | 98% | 96% | 102% | 100% | |||||||||||
| Mar 2026 | 100% | 102% | 102% | 99% | 99% | 99% | 99% | ||||||||||||
| Apr 2026 | 100% | 100% | 100% | 99% | 99% | 99% | |||||||||||||
| May 2026 | 100% | 100% | 100% | 100% | 100% | ||||||||||||||
| Jun 2026 | 100% | 109% | 112% | 122% | |||||||||||||||
| Jul 2026 | 100% | 100% | 99% | ||||||||||||||||
| Aug 2026 | 100% | 97% |